Tiziana Life Sciences Hosting Key Opinion Leader Virtual Eve

Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that it will host a virtual Key Opinion Leader (KOL) webinar event, “Foralumab Clinical Update in Multiple Sclerosis: A Landmark ...

Related Keywords

Boston , Massachusetts , United States , India , Toronto , Ontario , Canada , Philadelphia , Pennsylvania , Irina Koffler , Lawrence Steinman , Neuromyelitis Optica , Robertl Kroc , Howardl Weiner , Tarun Singhal , Howard Weiner , Hana Malik , Tanuja Chitnis , Brigham Pediatric Ms Center , Professor Of Neurology At Harvard Medical School , Imaging Program In Neurologic Diseases , Tiziana Life Sciences Ltd Nasdaq , Founder Of The Partners Multiple Sclerosis Center , Stanford University Interdepartmental Program In Immunology , Neurological Sciences , Harvard Medical School , University Of Toronto Medical School , Tiziana Life Sciences , International Pediatric Ms Workgroup , Tiziana Life Sciences Ltd , India Institute Of Medical Sciences , Ann Romney Center , Business Development , Life Sciences Ltd , Key Opinion Leader , Clinical Update , Multiple Sclerosis , Landmark Study , Massachusetts General Hospital , Stanford Medicine , Secondary Progressive Multiple Sclerosis , Partners Multiple Sclerosis Center , Neurologic Diseases , Show Science , Medical School , Neurology Endowed , Mass General Brigham Pediatric , Mass General Hospital , Toronto Medical School , Harvard Medical , International Pediatric , Assistant Professor , All India Institute , Medical Sciences , Norepinephrine Transporter , Stanford University Interdepartmental Program , Life Sciences , Investor Relations ,